WallStSmart

Acme United Corporation (ACU)vsUnilever PLC ADR (UL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Unilever PLC ADR generates 24792% more annual revenue ($50.50B vs $202.88M). UL leads profitability with a 18.8% profit margin vs 4.7%. ACU appears more attractively valued with a PEG of 1.54. ACU earns a higher WallStSmart Score of 50/100 (C-).

ACU

Buy

50

out of 100

Grade: C-

Growth: 4.0Profit: 5.0Value: 4.0Quality: 8.5
Piotroski: 5/9Altman Z: 3.97

UL

Hold

46

out of 100

Grade: D+

Growth: 2.0Profit: 8.5Value: 4.3Quality: 5.0
Piotroski: 4/9Altman Z: 2.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACUSignificantly Overvalued (-36.1%)

Margin of Safety

-36.1%

Fair Value

$32.18

Current Price

$47.50

$15.32 premium

UndervaluedFair: $32.18Overvalued

Intrinsic value data unavailable for UL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACU2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.9710/10

Safe zone — low bankruptcy risk

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

UL4 strengths · Avg: 8.8/10
Return on EquityProfitability
76.2%10/10

Every $100 of equity generates 76 in profit

Market CapQuality
$131.92B9/10

Large-cap with strong market position

Operating MarginProfitability
20.1%8/10

Strong operational efficiency at 20.1%

Free Cash FlowQuality
$5.48B8/10

Generating 5.5B in free cash flow

Areas to Watch

ACU4 concerns · Avg: 3.3/10
PEG RatioValuation
1.544/10

Expensive relative to growth rate

Market CapQuality
$186.48M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

UL4 concerns · Avg: 2.3/10
Debt/EquityHealth
1.913/10

Elevated debt levels

PEG RatioValuation
11.742/10

Expensive relative to growth rate

Revenue GrowthGrowth
-3.2%2/10

Revenue declined 3.2%

EPS GrowthGrowth
-3.4%2/10

Earnings declined 3.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : ACU

The strongest argument for ACU centers on Altman Z-Score, Price/Book. Revenue growth of 13.8% demonstrates continued momentum.

Bull Case : UL

The strongest argument for UL centers on Return on Equity, Market Cap, Operating Margin. Profitability is solid with margins at 18.8% and operating margin at 20.1%.

Bear Case : ACU

The primary concerns for ACU are PEG Ratio, Market Cap, Profit Margin. Thin 4.7% margins leave little buffer for downturns.

Bear Case : UL

The primary concerns for UL are Debt/Equity, PEG Ratio, Revenue Growth. Debt-to-equity of 1.91 is elevated, increasing financial risk.

Key Dynamics to Monitor

ACU profiles as a value stock while UL is a declining play — different risk/reward profiles.

ACU carries more volatility with a beta of 0.51 — expect wider price swings.

ACU is growing revenue faster at 13.8% — sustainability is the question.

UL generates stronger free cash flow (5.5B), providing more financial flexibility.

Bottom Line

ACU scores higher overall (50/100 vs 46/100) and 13.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Acme United Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Acme United Corporation supplies cutting, measuring, first aid, sharpening and safety products for the school, home, office, hardware, sporting goods and industrial markets in the United States, Canada, Europe and Asia. The company is headquartered in Shelton, Connecticut.

Unilever PLC ADR

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Unilever PLC is a fast moving consumer goods company in Asia, Africa, the Middle East, Turkey, Russia, Ukraine, Belarus, America and Europe. The company is headquartered in London, the United Kingdom.

Want to dig deeper into these stocks?